Skip to main content Skip to section navigation Skip to footer
Careers Search
Grace Therapeutics, Inc. Homepage
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • GTx-104
    • Overview
    • STRIVE-ON Trial
    • Publications
  • Our Pipeline
  • Newsroom
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
  • Careers
  • Search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Company Profile
    • Presentations
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
    • Tax Notifications
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Events
  • Email Alerts
Apr 9, 2025 8:00 am EDT
Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
Feb 25, 2025 8:00 am EST
Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
Feb 13, 2025 8:00 am EST
Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update
Feb 10, 2025 8:05 am EST
Grace Therapeutics Announces Private Placement Financing of up to $30 Million
Feb 10, 2025 8:01 am EST
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Jan 7, 2025 8:00 am EST
Grace Therapeutics to Participate in Upcoming Investor Events January 2025
Dec 4, 2024 8:00 am EST
Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
Nov 13, 2024 8:00 am EST
Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update
Oct 30, 2024 8:00 am EDT
Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024
Oct 25, 2024 8:00 am EDT
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 29
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Grace Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences